Research paper

View All
  • Daniel Huff

    Histiocytic Sarcoma Treated with Pembrolizumab: A Case Report and Literature Review

    Get Access
  • Hamzah Abu-Sbeih

    The Impact of Immune Checkpoint Inhibitor-Related Adverse Events and Their Immunosuppressive Treatment on Patients’ Outcomes

    Get Access
  • Abdul Rahman Jazieh

    Erlotinib in Patients with Advanced Non-small Cell Lung Cancer in Middle Eastern Population

    Get Access
  • Shelby L Kubicki

    Toxic Epidermal Necrolysis During Cotherapy with Ipilimumab and Nivolumab

    Get Access
  • Aung Naing

    Being Realistic and Optimistic in Curing Cancer

    Get Access
  • Jennifer Gardner

    Inflammatory Colitis after Treatment of Melanoma with Talimogene Laherparepvec (T-VEC)

    Get Access
  • Tito R Mendoza

    Understanding the Toxicity of Cancer Immunotherapies: Use of Patient-Reported Outcomes

    Get Access
  • Akash Jain

    Pneumonitis After Precision Oncology Therapies: A Concise Review

    Get Access
  • David D Stenehjem

    Pembrolizumab in Advanced Gastrointestinal Malignancies with Defective DNA Mismatch Repair: A Case Series

    Get Access
  • Macartney E Welborn

    Pyoderma Gangrenosum Following Initiation of Immune Checkpoint Inhibitor Therapy

    Get Access
Your Feedback